CA2336774A1 - Angiogenesis inhibitors - Google Patents

Angiogenesis inhibitors Download PDF

Info

Publication number
CA2336774A1
CA2336774A1 CA002336774A CA2336774A CA2336774A1 CA 2336774 A1 CA2336774 A1 CA 2336774A1 CA 002336774 A CA002336774 A CA 002336774A CA 2336774 A CA2336774 A CA 2336774A CA 2336774 A1 CA2336774 A1 CA 2336774A1
Authority
CA
Canada
Prior art keywords
naphthyl
represented
nmr
mhz
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002336774A
Other languages
English (en)
French (fr)
Inventor
Kyriacos C. Nicolaou
John Trujillo
Kelly Chibale
Bernd Jandeleit
Simon Goodman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Scripps Research Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2336774A1 publication Critical patent/CA2336774A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
CA002336774A 1998-07-06 1999-07-06 Angiogenesis inhibitors Abandoned CA2336774A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11088598A 1998-07-06 1998-07-06
US09/110,885 1998-07-06
PCT/US1999/015252 WO2000001383A1 (en) 1998-07-06 1999-07-06 Angiogenesis inhibitors

Publications (1)

Publication Number Publication Date
CA2336774A1 true CA2336774A1 (en) 2000-01-13

Family

ID=22335452

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002336774A Abandoned CA2336774A1 (en) 1998-07-06 1999-07-06 Angiogenesis inhibitors

Country Status (14)

Country Link
EP (1) EP1094812A4 (ja)
JP (1) JP2002519377A (ja)
KR (1) KR20010079497A (ja)
CN (1) CN1308534A (ja)
AU (1) AU4862599A (ja)
BR (1) BR9911885A (ja)
CA (1) CA2336774A1 (ja)
HU (1) HUP0104509A3 (ja)
ID (1) ID28125A (ja)
NO (1) NO20010085L (ja)
PL (1) PL345574A1 (ja)
SK (1) SK242001A3 (ja)
WO (1) WO2000001383A1 (ja)
ZA (1) ZA200007405B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
JP2003531141A (ja) 2000-04-17 2003-10-21 セルテック アール アンド ディ リミテッド エナミン誘導体
US6486174B2 (en) 2000-08-07 2002-11-26 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
AU2003212558A1 (en) 2002-03-20 2003-09-29 Koninklijke Philips Electronics N.V. Active matrix electroluminescent display devices, and their manufacture
US8586033B2 (en) * 2003-12-03 2013-11-19 The Scripps Research Institute Integrin αIIbβ3 specific antibodies and peptides
EP3381460A4 (en) * 2015-11-26 2019-07-17 Daiwa Pharmaceutical Co., Ltd INHIBITOR OF ANGIOGENESIS
CN109535035A (zh) * 2019-01-08 2019-03-29 吉尔生化（上海）有限公司 一种n-苄氧羰基-3-氨基-丙氨酸叔丁酯的制备方法
CN113773260B (zh) * 2021-08-26 2023-09-22 华南师范大学 一种类共价有机材料及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502484A (ja) * 1992-10-14 1996-03-19 メルク エンド カンパニー インコーポレーテッド フィブリノゲンリセプタ拮抗剤
AU675689B2 (en) * 1992-12-01 1997-02-13 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0760658B1 (en) * 1994-05-27 2002-11-13 Merck & Co. Inc. Compounds for inhibiting osteoclast-mediated bone resorption
ATE227268T1 (de) * 1996-04-10 2002-11-15 Merck & Co Inc Alpha v beta 3 antagonisten

Also Published As

Publication number Publication date
HUP0104509A3 (en) 2002-05-28
SK242001A3 (en) 2001-10-08
BR9911885A (pt) 2001-03-27
WO2000001383A1 (en) 2000-01-13
EP1094812A4 (en) 2003-04-16
ZA200007405B (en) 2001-09-21
EP1094812A1 (en) 2001-05-02
ID28125A (id) 2001-05-03
CN1308534A (zh) 2001-08-15
JP2002519377A (ja) 2002-07-02
NO20010085L (no) 2001-03-05
AU4862599A (en) 2000-01-24
NO20010085D0 (no) 2001-01-05
PL345574A1 (en) 2001-12-17
HUP0104509A2 (hu) 2002-04-29
KR20010079497A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
Katritzky et al. Recent developments in guanylating agents
AU702487B2 (en) Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
EP1140809B1 (en) New biphenyl and biphenyl-analogous compounds as integrin antagonists
JP4177484B2 (ja) 置換されたジアミノカルボン酸
Nicolaou et al. Design, synthesis and biological evaluation of nonpeptide integrin antagonists
AU749555B2 (en) Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
CA2250464A1 (en) Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
US20030087950A1 (en) New alpha-amino acid sulphonyl compounds
AU6528999A (en) New hydrazide compounds, a process for their preparation and pharmaceutical compositions containing them
US20020016461A1 (en) Biphenyl and biphenyl-analogous compounds as integrin antagonists
FR2620451A1 (fr) Nouveaux inhibiteurs de la renine, leur preparation et leur utilisation comme medicaments
IL141997A (en) Derivatives of N- (Iminomethyl) Amine, their preparation, use as drugs and preparations containing them
CA2336774A1 (en) Angiogenesis inhibitors
CA2399792A1 (en) Substituted amino acids as neutral sphingomyelinase inhibitors
Domagala et al. A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: The 2, 2′-dithiobisbenzamides
TW461880B (en) New naphthyl- and anilide-substituted sulphonamides
CA2075547A1 (en) Trifluoromethyl-containing pseudopeptides
KR20030031001A (ko) 사이클릭 우레아 화합물 및 그의 제조방법
EP1480941B1 (en) Urea derivatives as hiv aspartyl protease inhibitors
HUT65911A (en) Process for preparing hydroxy-ethylene-isoster-tupe compounds containing dithiolanyl-glycine and pharmaceutical compositions containing them
MXPA00012759A (en) Angiogenesis inhibitors
JP2004506623A (ja) アミノ酸から誘導された７員環スルファミドおよびその合成方法
Sharma et al. Synthesis of new 2-(substituted benzothiazolylcarbamoyl) benzimidazoles as potential CNS depressants
US6258976B1 (en) Process for the preparation of polyamines and polyamine derivatives
CZ20004656A3 (cs) RGD mimetická látka, způsob její produkce a způsob pro diferenční inhibování buněčné adheze

Legal Events

Date Code Title Description
FZDE Discontinued